ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 118 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $75,000 | +25.0% | 51,511 | +21.2% | 0.00% | – |
Q4 2016 | $60,000 | -23.1% | 42,506 | -5.0% | 0.00% | – |
Q3 2016 | $78,000 | +5.4% | 44,740 | +2.8% | 0.00% | -100.0% |
Q2 2016 | $74,000 | -7.5% | 43,540 | +7.1% | 0.00% | 0.0% |
Q1 2016 | $80,000 | +12.7% | 40,640 | +9.4% | 0.00% | 0.0% |
Q4 2015 | $71,000 | -12.3% | 37,140 | -12.2% | 0.00% | 0.0% |
Q3 2015 | $81,000 | -63.2% | 42,290 | -10.9% | 0.00% | -50.0% |
Q2 2015 | $220,000 | +14.0% | 47,465 | +7.4% | 0.00% | 0.0% |
Q1 2015 | $193,000 | +49.6% | 44,190 | +18.8% | 0.00% | +100.0% |
Q4 2014 | $129,000 | -22.3% | 37,190 | -6.0% | 0.00% | -50.0% |
Q3 2014 | $166,000 | -33.1% | 39,545 | -6.7% | 0.00% | -33.3% |
Q2 2014 | $248,000 | +26.5% | 42,395 | +36.3% | 0.00% | 0.0% |
Q1 2014 | $196,000 | +79.8% | 31,095 | +66.6% | 0.00% | +50.0% |
Q4 2013 | $109,000 | +153.5% | 18,670 | +127.7% | 0.00% | +100.0% |
Q3 2013 | $43,000 | -27.1% | 8,200 | +6.5% | 0.00% | 0.0% |
Q2 2013 | $59,000 | – | 7,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 867,700 | $5,085,000 | 1.68% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,369,066 | $25,603,000 | 1.03% |
Lyons Wealth Management, LLC. | 56,775 | $334,000 | 0.30% |
Callan Capital, LLC | 66,118 | $387,000 | 0.10% |
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 383,050 | $2,245,000 | 0.06% |
FCG ADVISORS, LLC | 10,600 | $62,000 | 0.05% |
OppenheimerFunds, Inc. | 7,000,000 | $41,020,000 | 0.04% |
NEXT Financial Group, Inc | 19,704 | $86,000 | 0.04% |
WELLINGTON MANAGEMENT GROUP LLP | 27,893,387 | $163,455,000 | 0.04% |
MURPHY CAPITAL MANAGEMENT INC | 45,000 | $263,000 | 0.04% |